 |
|
|
|
|
|
 Introduction
Human
Veterinary
Environmental
Industrial
Agricultural
MSG
Introduction
Medical
Veterinary
Environmental
Industrial
Agricultural
Introduction
Susceptibility
MIC Database
Procedures
Histopathology
Introduction
Abbreviations
Links
CME
Conference
Highlights
Bibliography
Glossary
Good Books
Events Calendar
Introduction
Our Mission
Editorial Board
Editorial Staff
Supporters
Contributors
Legal Stuff
Privacy Policy
Kudos
Introduction
Descriptions
Synonyms
Image Bank
Lecture Bank
Video Bank
This page updated:
1/27/2007 9:23:00 AM
DoctorFungus - All Rights Reserved
© 2007 Copyright
& Privacy Policy
Site built and designed for doctorfungus by Webillustrated
|
 |
 |
|
|
You are here:
The Fungi
> Descriptions >
|
Chrysosporium spp.
(described by Corda in 1833)
|  |
Kingdom: Fungi
Phylum: Ascomycota
Class: Euascomycetes
Order:Onygenales
Family: Onygenaceae
Genus: Chrysosporium
Chrysosporium is a keratinophilic filamentous fungus commonly isolated from soil, plant material, dung, and birds. It lives on remains of hairs and feathers in soil. The telemorphs of Chrysosporium spp. are included in the genera Aphanoascus, Nannizziopsis, and Uncinocarpus. As well as being a common contaminant, Chrysosporium is occasionally isolated from human infections.
The genus Chrysosporium contains several species. The most common ones are Chrysosporium keratinophilum, Chrysosporium tropicum, Chrysosporium merdarium, Chrysosporium inops, Chrysosporium pannicola, Chrysosporium queenslandicum, and Chrysosporium zonatum. Another species of special interest, classified as Emmonsia parva on the ecological basis, is occasionally named as Chrysosporium parvum as well. Please see our detailed discussion about the classification of Emmonsia parva.
The species of Chrysosporium are differentiated from each other by the texture of the colony and morphology, location, and size of the conidia. Also, some species, particularly Chrysosporium pannicola, do not grow at 37°C [531].
See the summary of synonyms and telemorph-anamorph relations for the Chrysosporium spp.
Chrysosporium spp. may cause skin infections and onychomycosis in humans. In addition to these superficial infections, Chrysosporium spp. have occasionally been isolated from systemic infections in bone marrow transplant recipients and in patients with chronic granulomatous disease [1581, 1952]. The high mortality rate of systemic Chrysosporium infections is noteworthy [1581].
Chrysosporium colonies grow moderately rapidly at 25°C. The morphology of the colonies is very variable. They may be granular, woolly, or cottony and flat, or raised and folded in appearance. From the front, the color is white cream, yellow or tan to pale brown. The reverse is white to brown [531, 1295, 2202].
Chrysosporium produces hyphae, conidia (aleuriconidia), and arthroconidia. Hyphae are septate while the conidia are hyaline, broad-based, one-celled, and smooth- or rough-walled. These conidia are broader than the vegetative hyphae and occur terminally on pedicels, along the sides of the hyphae, or in intercalary positions. The conidia usually have an annular frill which is the reminant of the hyphal wall that remains after detachment from the hypha. Arthroconidia, on the other hand, are abundant and larger than their parent hyphae in diameter. In addition, Chrysosporium parvum forms enlarged, thick-walled cells (adiaspores) at 37-40°C [531, 1295, 2202].
Blastomyces dermatitidis
Geomyces spp.
Microsporum spp.
Sepedonium spp.
Trichophyton spp.
Chrysosporium differs from Blastomyces by not being dimorphic; from Microsporum and Trichophyton by lacking macroconidia; from Geomyces by lacking branched, fertile hyphae on erect conidiophores; and from Sepedonium by having hyaline conidia.
No special precautions other than general laboratory precautions are required.
Very limited data are available. Amphotericin B, itraconazole, ketoconazole, and voriconazole tend to yield low MICs for Chrysosporium keratinophilum isolates. Fluconazole MICs are relatively higher than those of the just noted antifungal agents. Flucytosine, on the other hand, appears to have no in vitro activity against these isolates [2432].
For MICs of various antifungal drugs for Chrysosporium, see our susceptibility database.
PubMed
GenBank
|
Chrysosporium spp. |
Chrysosporium xerophilum |
Emmonsia parva
|
|
|
References
531. de Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2000. Atlas of Clinical Fungi, 2nd ed, vol. 1. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
1295. Larone, D. H. 1995. Medically Important Fungi - A Guide to Identification, 3rd ed. ASM Press, Washington, D.C.
1581. Morrison, V. A., R. J. Haake, and D. J. Weisdorf. 1993. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore). 72:78-89.
1952. Roilides, E., L. Sigler, E. Bibashi, H. Katsifa, N. Flaris, and C. Panteliadis. 1999. Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections with this disease. J Clin Microbiol. 37:18-25.
2202. Sutton, D. A., A. W. Fothergill, and M. G. Rinaldi (ed.). 1998. Guide to Clinically Significant Fungi, 1st ed. Williams & Wilkins, Baltimore.
2432. Wildfeuer, A., H. P. Seidl, I. Paule, and A. Haberreiter. 1998. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses. 41:309-319.
|
|
|
 |
 |
Home |
Image Bank |
Lecture Bank |
Knowledgebase |
Site Map |
Contact Us |
The Fungi |
Mycoses |
Drugs |
Laboratory |
Education & Tools |
About Us
|
|
|
|